These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2435984)

  • 21. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
    Skjeldal OH; Stokke O; Norseth J; Lie SO
    Scand J Clin Lab Invest; 1986 May; 46(3):283-7. PubMed ID: 2424078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autopsy findings in two siblings with infantile Refsum disease.
    Chow CW; Poulos A; Fellenberg AJ; Christodoulou J; Danks DM
    Acta Neuropathol; 1992; 83(2):190-5. PubMed ID: 1373019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of Refsum's disease. Phytanic acid oxidase deficiency.
    Poulos A; Pollard AC; Mitchell JD; Wise G; Mortimer G
    Arch Dis Child; 1984 Mar; 59(3):222-9. PubMed ID: 6201142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders.
    Hughes JL; Poulos A; Robertson E; Chow CW; Sheffield LJ; Christodoulou J; Carter RF
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):255-64. PubMed ID: 1689088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refsum's disease and metabolism of phytanic acid.
    Stokke O; Refsum S
    Lancet; 1982 Apr; 1(8277):906-7. PubMed ID: 6175864
    [No Abstract]   [Full Text] [Related]  

  • 26. Biogenesis of peroxisomes in fetal liver.
    Espeel M; Depreter M; Nardacci R; D'Herde K; Kerckaert I; Stefanini S; Roels F
    Microsc Res Tech; 1997 Dec; 39(5):453-66. PubMed ID: 9408912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refsum disease, peroxisomes and phytanic acid oxidation: a review.
    Wanders RJ; Jansen GA; Skjeldal OH
    J Neuropathol Exp Neurol; 2001 Nov; 60(11):1021-31. PubMed ID: 11706932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical refsum disease with pipecolic acidemia and abnormal catalase distribution.
    Baumgartner MR; Jansen GA; Verhoeven NM; Mooyer PA; Jakobs C; Roels F; Espeel M; Fourmaintraux A; Bellet H; Wanders RJ; Saudubray JM
    Ann Neurol; 2000 Jan; 47(1):109-13. PubMed ID: 10632109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
    Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
    J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders.
    Hughes JL; Crane DI; Robertson E; Poulos A
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):459-68. PubMed ID: 7507276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
    Kase BF; Björkhem I
    Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new type of peroxisomal disorder with variable expression in liver and fibroblasts.
    Mandel H; Espeel M; Roels F; Sofer N; Luder A; Iancu TC; Aizin A; Berant M; Wanders RJ; Schutgens RB
    J Pediatr; 1994 Oct; 125(4):549-55. PubMed ID: 7931872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of phytanic acid in Refsum's disease.
    Billimoria JD; Clemens ME; Gibberd FB; Whitelaw MN
    Lancet; 1982 Jan; 1(8265):194-6. PubMed ID: 6172683
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 36. Phytol and peroxisome proliferation.
    Van den Branden C; Vamecq J; Wybo I; Roels F
    Pediatr Res; 1986 May; 20(5):411-5. PubMed ID: 2423950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
    Greter J; Lindstedt S; Steen G
    Clin Chem; 1983 Mar; 29(3):434-7. PubMed ID: 6186413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
    Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic catalase and ghostlike peroxisomes in the liver from a child with atypical chondrodysplasia punctata.
    Espeel M; Heikoop JC; Smeitink JA; Beemer FA; De Craemer D; Van den Berg M; Hashimoto T; Wanders RJ; Schutgens RB; Poll-The BT
    Ultrastruct Pathol; 1993; 17(6):623-36. PubMed ID: 8122328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
    Mihalik SJ; Rainville AM; Watkins PA
    Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.